On the recordDecember 17, 2013
During Mr. Forlenza's tenure as chairman, AdvaMedDx doubled the size of its membership and established itself as a credible voice on health care policy in Washington and around the world. Under Mr. Forlenza's leadership, the diagnostic industry has worked with a range of stakeholders to pursue initiatives that aim to reform and modernize the diagnostics regulatory and payment environment in order to keep pace with innovation and the changing health care landscape. AdvaMedDx works not only with Members of Congress and key public health agencies but also with organizations ranging from patient advocacy groups to cancer research societies to the World Health Organization.
